Cargando…

Effect of Dialysis on Antiplatelet Drug Efficacy in Uremic Patients with Coronary Heart Disease

BACKGROUND: Coronary intervention therapy is the main treatment for uremic patients with coronary heart disease. The studies on whether dialysis reduces the efficacy of dual antiplatelet drugs are limited. The aim of this study was to examine the effect of dialysis on antiplatelet drugs in uremic pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Dong-Liang, Zhao, Ting-Ting, Peng, Wen-Hua, Yang, Peng, Liu, Xiao-Fei, Zhang, Hu, Li, Xian-Lun, Wang, Yong, Zheng, Jin-Gang, Gao, Yan-Xiang, Lu, Hong-Kai, Wang, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555124/ https://www.ncbi.nlm.nih.gov/pubmed/28776542 http://dx.doi.org/10.4103/0366-6999.211888

Ejemplares similares

Uremic pruritus and long-term morbidities in the dialysis population
por: Ting, Sze-Wen, et al.
Publicado: (2020)

Calcific Uremic Arteriolopathy in Peritoneal Dialysis Populations
por: New, Nicholas, et al.
Publicado: (2011)

Assessment of uremic sarcopenia in dialysis patients: An update
por: Lin, Yu-Li, et al.
Publicado: (2021)

A Uremic Pig Model for Peritoneal Dialysis
por: de Vries, Joost C., et al.
Publicado: (2022)

Clinical outcomes of prolonged dual antiplatelet therapy after coronary drug-eluting stent implantation in dialysis patients
por: Park, Seokwoo, et al.
Publicado: (2020)

A Comparison of Uremic Pruritus in Patients Receiving Peritoneal Dialysis and Hemodialysis
por: Wu, Hon-Yen, et al.
Publicado: (2016)

Effect of Rabeprazole and Rebamipide in the Treatment of Upper Gastrointestinal Hemorrhage Associated with Dual Antiplatelet Therapy in Elderly Patients with Coronary Heart Disease
por: Jia, Rong-Jie, et al.
Publicado: (2022)

Efficacy and Safety of Antiplatelet Therapy Plus Xa Factor Inhibitors in Patients with Coronary Heart Disease: A Meta-Analysis
por: Chen, Hongsen, et al.
Publicado: (2019)

Factors Associated with Uremic Pruritus in Patients Undergoing Peritoneal Dialysis
por: Minato, Saori, et al.
Publicado: (2020)

Efficacy and safety of new oral anticoagulants combined with antiplatelet drugs in the treatment of coronary heart disease: Systematic evaluation and meta‐analysis
por: Saiyitijiang, Alimila, et al.
Publicado: (2022)

Efficacy and safety of dual antiplatelet therapy after percutaneous coronary drug-eluting stenting: A network meta-analysis
por: Luo, Lin, et al.
Publicado: (2022)

Triple versus dual antiplatelet therapy for coronary heart disease patients undergoing percutaneous coronary intervention: A meta-analysis
por: ZHOU, HONG, et al.
Publicado: (2013)

Impact of Anemia and Dual Antiplatelet Therapy on Mortality in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents
por: Wang, Huili, et al.
Publicado: (2015)

The safety and efficacy of oral anticoagulants with dual versus single antiplatelet therapy in patients after percutaneous coronary intervention: A meta-analysis
por: Chen, Jie, et al.
Publicado: (2017)

Comparative efficacy of Chinese herbal medicines for dialysis patients with uremic pruritus: A systematic review and network meta-analysis
por: Lu, Ping-Hsun, et al.
Publicado: (2023)

Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease
por: Ye, Fei, et al.
Publicado: (2021)

Comparison of uremic pruritus between patients undergoing hemodialysis and peritoneal dialysis
por: Min, Ji-Won, et al.
Publicado: (2016)

Association of Uremic Toxins and Inflammatory Markers with Physical Performance in Dialysis Patients
por: Pajek, Maja, et al.
Publicado: (2018)

Is Fluorescence Valid to Monitor Removal of Protein Bound Uremic Solutes in Dialysis?
por: Arund, Jürgen, et al.
Publicado: (2016)

Successful treatment of calcific uremic arteriolopathy in a pediatric dialysis patient
por: Amin, Nimisha, et al.
Publicado: (2010)

Differences in Dialysis Efficacy Have Limited Effects on Protein-Bound Uremic Toxins Plasma Levels over Time
por: Krieter, Detlef H., et al.
Publicado: (2019)

Uremic Pruritus, Dialysis Adequacy, and Metabolic Profiles in Hemodialysis Patients: A Prospective 5-Year Cohort Study
por: Ko, Mei-Ju, et al.
Publicado: (2013)

Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients
por: Han, Jialun, et al.
Publicado: (2023)

Longer or shorter dual antiplatelet therapy in dialysis patients receiving a coronary drug-eluting stent? A rope game still ongoing
por: Burlacu, Alexandru, et al.
Publicado: (2020)

Impact of anticoagulation and antiplatelet therapy on dialysis catheter fibrin sheath formation
por: Linch, Forrest B., et al.
Publicado: (2022)

Antiplatelet Therapy and Percutaneous Coronary Interventions
por: Davanzo, Rene Hameau, et al.
Publicado: (2021)

Predisposing factors and uremic pericardial effusion among ESRD patients undergoing dialysis()
por: Aghsaeifard, Ziba, et al.
Publicado: (2022)

Bioengineered Kidney Tubules Efficiently Clear Uremic Toxins in Experimental Dialysis Conditions
por: Faria, João, et al.
Publicado: (2023)

Prognostic importance and determinants of uremic pruritus in patients receiving peritoneal dialysis: A prospective cohort study
por: Wu, Hon-Yen, et al.
Publicado: (2018)

Efficacy, Safety, and Role of Antiplatelet Drugs in the Management of Acute Coronary Syndrome: A Comprehensive Review of Literature
por: Abubakar, Muhammad, et al.
Publicado: (2023)

Correction: Uremic Pruritus, Dialysis Adequacy, and Metabolic Profiles in Hemodialysis Patients: A Prospective 5-Year Cohort Study
por: Ko, Mei-Ju, et al.
Publicado: (2013)

The Efficacy of Rosuvastatin, Amlodipine, and Aspirin in the Treatment of Hypertension with Coronary Heart Disease and Its Effect on Platelet Aggregation
por: Fu, Jianli, et al.
Publicado: (2022)

Successful hemostasis and resection of a bleeding gastric polyp by endoscopic banding ligation in a uremic patient taking antiplatelet agent
por: Hsu, Ping-I, et al.
Publicado: (2016)

Cost-effectiveness of antiplatelet drugs after percutaneous coronary intervention
por: Wisløff, Torbjørn, et al.
Publicado: (2016)

Comparison of mesenchymal stromal cells from peritoneal dialysis effluent with those from umbilical cords: characteristics and therapeutic effects on chronic peritoneal dialysis in uremic rats
por: Du, Yangchun, et al.
Publicado: (2021)

Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study
por: Yan, Hua, et al.
Publicado: (2020)

Anticoagulant Activities of Indobufen, an Antiplatelet Drug
por: Liu, Jia, et al.
Publicado: (2018)

Haemolytic uremic syndrome following fire ant bites
por: Lee, Yi-Che, et al.
Publicado: (2014)

Combined Therapy with Traditional Chinese Medicine and Antiplatelet Drugs for Ischemic Heart Disease: Mechanism, Efficacy, and Safety
por: Yu, Zongliang, et al.
Publicado: (2021)

Evaluation of a system for sorbent‐assisted peritoneal dialysis in a uremic pig model
por: van Gelder, Maaike K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tlf3ummoa40chi33ro8595rurq